Loading...
The antitumor capacity of mesothelin-CAR-T cells in targeting solid tumors in mice
Since the approval of chimeric antigen receptor (CAR) T cell therapy targeting CD19 by the FDA, CAR-T cell therapy has received increasing attention as a new method for targeting tumors. Although CAR-T cell therapy has a good effect against hematological malignancies, it has been less effective agai...
Na minha lista:
| Udgivet i: | Mol Ther Oncolytics |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Gene & Cell Therapy
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7943972/ https://ncbi.nlm.nih.gov/pubmed/33738341 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2021.02.013 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|